PITPNM2-AS1: A Promising Drug Target / Biomarker (G100507091)

Target Name: PITPNM2-AS1

NCBI ID: G100507091

PITPNM2-AS1

Other Name(s): PITPNM2 antisense RNA 1

PITPNM2-AS1: A Promising Drug Target / Biomarker

Pittenger DM3 is a protein that is expressed in various tissues of the body, including the brain. It is a member of the T-cell receptor (TCR) family and is involved in the regulation of cell survival and proliferation. PITTENGER DM3 has also been shown to play a role in the development and progression of various diseases, including cancer. As a result, it is of great interest as a potential drug target or biomarker.

Drug Target Potential

Pittenger DM3 is a potential drug target due to its involvement in the regulation of cell survival and proliferation. It has been shown to play a role in the regulation of cell adhesion, a process that is critical for the development and survival of tissues. Additionally, it has been shown to be involved in the regulation of cell apoptosis, a process that is regulated by various signaling pathways, including the T-cell signaling pathway.

Studies have also shown that PITTENGER DM3 is involved in the regulation of inflammation, a process that is critical for the development and progression of various diseases, including cancer. It has been shown to play a role in the regulation of immune cell function and the production of antibodies, which are important for the regulation of inflammation.

Biomarker Potential

Pittenger DM3 has also been shown to be a potential biomarker for various diseases, including cancer. The expression of PITTENGER DM3 has been shown to be associated with the development and progression of various diseases, including cancer. This suggests that PITTENGER DM3 may be a useful biomarker for the diagnosis and treatment of these diseases.

Pittenger DM3 has also been shown to be involved in the regulation of cell signaling pathways, including the T-cell signaling pathway. This suggests that it may be a useful target for drugs that are designed to modulate these signaling pathways.

Conclusion

In conclusion, PITTENGER DM3 is a protein that is of great interest as a potential drug target or biomarker. Its involvement in the regulation of cell survival and proliferation, as well as its involvement in the regulation of inflammation and immune cell function, make it a promising target for the development of drugs that can modulate these processes. Further research is needed to determine the full potential of PITTENGER DM3 as a drug target or biomarker.

Protein Name: PITPNM2 Antisense RNA 1

The "PITPNM2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PITPNM2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets